spacer
home > pmps > summer 2019 > leaving on a jet plane
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Leaving on a Jet Plane

‘Leaving on a jet plane’ is the title of one of John Denver’s greatest hits. However, it is also what an increasing number of pharmaceutical products do every day, when the results of Medicon Valley based R&D, commercialisation, and manufacturing are sent out to make a difference worldwide.

The binational Danish-Swedish life sciences cluster Medicon Valley consists of the Region Zealand, the Danish Capital Region, and the Swedish region Skåne. It is not only host to cutting-edge public and private life sciences R&D in, for instance, oncology, dermatology, diabetes, fertility, and CNS-related diseases, but also the world’s largest insulin manufacturing site owned by Novo Nordisk and located in the Danish city of Kalundborg. Additionally, Medicon Valley-based companies such as LEO Pharma, Baxter, Coloplast, Ferring, and Lundbeck have substantial local production and/or R&D facilities; this makes Copenhagen Airport a central logistics hub and, since it serves Denmark and South Sweden alike, the most important airport in the Nordics from a life sciences perspective.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Petter Hartman is the CEO of Medicon Valley Alliance since June 2015 and holds a Masters in Political Science from the University of Lund, Sweden. At Medicon Valley Alliance, Petter is involved in future strategies for the Medicon Valley region, general management within the public sector, project management, and pharma R&D. Petter comes from a post as Funding Manager at Medicon Valley Alliance. Prior to joining, Petter worked for the Secretariat for Interreg IV A Öresund-Kattegat- Skagerrak, Copenhagen, as a project consultant with special responsibility for issues concerning cross-border relations and labourmarket integration projects.
spacer
Petter Hartman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its dual-terminal operations seamlessly

Completing the gradual transition process to Istanbul Airport, one of the largest airports of the world, the global air cargo brand Turkish Cargo maintains its dual-terminal operations with full capacity on 7/24 basis without any sales restriction.
More info >>

White Papers

The BioPharmaSpec Approach”: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement